Literature DB >> 9259317

A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.

K B Cleutjens1, H A van der Korput, C C Ehren-van Eekelen, R A Sikes, C Fasciana, L W Chung, J Trapman.   

Abstract

Prostate-specific antigen (PSA) is a kallikrein-like serine protease, which is almost exclusively synthesized in the luminal epithelial cells of the human prostate. PSA expression is androgen regulated. Previously, we characterized in vitro the proximal promoter, and a strong enhancer region, approximately 4 kb upstream of the PSA gene. Both regions are needed for high, androgen-regulated activity of the PSA promoter in LNCaP cells. The goal of the present study is the in vivo characterization of the PSA promoter. Three transgenic mouse lines carrying the Escherichia coli LacZ gene, driven by the 632-bp proximal PSA promoter, and three lines with LacZ, driven by the 6-kb PSA promoter, were generated. Expression of the LacZ reporter gene was analyzed in a large series of tissues. Transgene expression could not be demonstrated in any of the transgenic animals carrying the proximal PSA promoter. All three lines carrying the 6-kb PSA promoter showed lateral prostate-specific beta-galactosidase activity. Transgene expression was undetectable until 8 weeks after birth. Upon castration, beta-galactosidase activity rapidly declined. It could be restored by subsequent androgen administration. A search for mouse PSA-related kallikrein genes expressed in the prostate led to the identification of mGK22, which was previously demonstrated to be expressed in the submandibular salivary gland. Therefore, the 6-kb PSA-LacZ transgene followed the expression pattern of the PSA gene in humans, which is almost completely prostate-specific, rather than that of mGK22 in mice. In conclusion, the 6-kb promoter fragment appears to contain most, if not all, information for androgen regulation and prostate specificity of the PSA gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259317     DOI: 10.1210/mend.11.9.9974

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  25 in total

Review 1.  Specific targeting of gene therapy to prostate cancer using a two-step transcriptional amplification system.

Authors:  Marxa L Figueiredo; Makoto Sato; Mai Johnson; Lily Wu
Journal:  Future Oncol       Date:  2006-06       Impact factor: 3.404

2.  Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate.

Authors:  June Liu; Laura E Pascal; Sudhir Isharwal; Daniel Metzger; Raquel Ramos Garcia; Jan Pilch; Susan Kasper; Karin Williams; Per H Basse; Joel B Nelson; Pierre Chambon; Zhou Wang
Journal:  Mol Endocrinol       Date:  2011-09-22

3.  Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).

Authors:  Eleftherios P Diamandis; Frank Z Stanczyk; Sarah Wheeler; Anu Mathew; Martin Stengelin; Galina Nikolenko; Eli N Glezer; Marshall D Brown; Yingye Zheng; Yen-Hao Chen; Hsiao-Li Wu; Ricardo Azziz
Journal:  Clin Chem Lab Med       Date:  2017-10-26       Impact factor: 3.694

4.  Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy.

Authors:  M Iyer; F B Salazar; X Lewis; L Zhang; L Wu; M Carey; S S Gambhir
Journal:  Transgenic Res       Date:  2005-02       Impact factor: 2.788

5.  Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1.

Authors:  Tao Qiu; William E Grizzle; Denise K Oelschlager; Xing Shen; Xu Cao
Journal:  EMBO J       Date:  2006-12-21       Impact factor: 11.598

6.  Distinct regulatory elements mediate the dynamic expression pattern of Nkx3.1.

Authors:  Hui Chen; Laura N Mutton; Gail S Prins; Charles J Bieberich
Journal:  Dev Dyn       Date:  2005-12       Impact factor: 3.780

Review 7.  Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era.

Authors:  Juan M Arriaga; Cory Abate-Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

8.  Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex.

Authors:  Maggie C Louie; Hong Qiong Yang; Ai-Hong Ma; Wei Xu; June X Zou; Hsing-Jien Kung; Hong-Wu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

9.  A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland.

Authors:  Ryan P McMullin; Albert Dobi; Laura N Mutton; András Orosz; Shilpi Maheshwari; Cooduvalli S Shashikant; Charles J Bieberich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 10.  Genetically engineered mouse models of prostate cancer.

Authors:  Maxime Parisotto; Daniel Metzger
Journal:  Mol Oncol       Date:  2013-02-14       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.